T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 | +$4.06B | |
| 2 | +$2.93B | |
| 3 | +$2.35B | |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| 1 | +$3.44B | |
| 2 | +$2.51B | |
| 3 | +$2.39B | |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| 1 | Technology | 36.31% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Sweetgreen
SG
$668M
| $34.5M | ﹤0.01% |
4,322,219
-2,235,473
|
|
||
902
Oric Pharmaceuticals
ORIC
$1.41B
| $34.5M | ﹤0.01% |
2,871,327
+108,412
|
|
||
903
Monte Rosa Therapeutics
GLUE
$1.3B
| $34.4M | ﹤0.01% |
4,637,060
-1,688,598
|
|
||
904
Prestige Consumer Healthcare
PBH
$3.07B
| $34.2M | ﹤0.01% |
547,865
+16,256
|
|
||
905
Sportradar
SRAD
$5.34B
| $34.1M | ﹤0.01% |
+1,269,245
|
|
||
906
Citizens Financial Group
CFG
$24.9B
| $33.8M | ﹤0.01% |
636,147
-2,575
|
|
||
907
Churchill Downs
CHDN
$5.99B
| $33.7M | ﹤0.01% |
347,808
+53,859
|
|
||
908
Rollins
ROL
$27B
| $33.6M | ﹤0.01% |
572,407
+4,446
|
|
||
909
W.R. Berkley
WRB
$25.4B
| $33.6M | ﹤0.01% |
438,818
+2,088
|
|
||
910
Warby Parker
WRBY
$3.11B
| $33.5M | ﹤0.01% |
1,213,433
+1,144,309
|
|
||
911
Wheaton Precious Metals
WPM
$67.5B
| $33.2M | ﹤0.01% |
297,261
-64,869
|
|
||
912
Lyft
LYFT
$5.3B
| $33.2M | ﹤0.01% |
1,508,209
+822,459
|
|
||
913
Service Corp International
SCI
$11.1B
| $33.1M | ﹤0.01% |
397,250
+57,592
|
|
||
914
Waters Corp
WAT
$29.2B
| $33M | ﹤0.01% |
110,056
+24,044
|
|
||
915
Invesco
IVZ
$10.6B
| $33M | ﹤0.01% |
1,436,526
+198,759
|
|
||
916
Devon Energy
DVN
$28.1B
| $32.9M | ﹤0.01% |
938,421
-44,437
|
|
||
917
Palomar
PLMR
$3.2B
| $32.8M | ﹤0.01% |
280,881
-65,695
|
|
||
|
RAPP
918
Rapport Therapeutics
RAPP
$1.46B
| $32.7M | ﹤0.01% |
1,102,391
-423,128
|
|
||
919
Grupo Aeroportuario del Sureste
ASR
$10B
| $32.7M | ﹤0.01% |
101,245
+3,998
|
|
||
920
Ryman Hospitality Properties
RHP
$6B
| $32.4M | ﹤0.01% |
361,749
+4,396
|
|
||
921
Huron Consulting
HURN
$2.28B
| $32.3M | ﹤0.01% |
220,003
+113,102
|
|
||
922
T. Rowe Price
TROW
$19.5B
| $32.2M | ﹤0.01% |
313,348
-2,173
|
|
||
923
Zai Lab
ZLAB
$2.11B
| $32.2M | ﹤0.01% |
948,671
+795,634
|
|
||
924
Stifel
SF
$11.2B
| $32M | ﹤0.01% |
281,775
+36,866
|
|
||
925
Blue Owl Capital
OWL
$6B
| $31.9M | ﹤0.01% |
1,884,154
+128,982
|
|